Search

The climate for R&D-based start-ups in Central and Eastern Europe should be improving. But there’s still a way to go, writes Mary Lisbeth D’Amico.

Czechoslovakia’s development authorities are to win a reputation for the country as a magnet for emerging biotech.

Researchers in Denmark have invented a bioplastic material made from dairy products that could replace traditional polymer-based packaging. The technology is currently available for licensing.

French researchers have discovered that an anti-rejection drug could treat Huntington's disease. Intellectual Property based on the research is available for licence.

134,073: the number of patents filed for via the Patent Cooperation Treaty in 2005, according to the World Intellectual Property Organization – a rise of 9.4 per cent over 2004.

Acrobot Ltd., a spin-out from Imperial College London, is currently fund raising and is seeking partnerships and licence agreements.

The time is not right to breathe back life into the European software patent, says Francisco Mingorance from the Business Software Alliance. Thomas Lau investigates.

Everyone wants to encourage innovation. But, says Alain de Serres from the OECD, a survey of the world’s leading industrial countries shows they are going about it in different ways and with very different results.

The Scotsman reports on a life sciences industry meeting in Edinburgh, and sparks off some thoughts about Qinetiq.

Not so much a geological specimen as something that will make nanotechnology happen, dendrimers are the young upstarts of the polymer family - but they have promise.

There's nothing light about the scope and ambitions of the University of Manchester's new interdisciplinary Photon Science Institute. The £40 million institute aims to be world-class in pioneering light and laser technologies.

Nanotechnology has the power to transform healthcare. But Europe will lose out to the United States unless it can mount a coherent approach to developing nanomedicine, says a new report.